QuiVad

Home / France / Eramet

Eramet

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 5.29% on February 27, 2020. The shaded band is the year shown above.

January 10, 2018 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

178 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 3, 2026Arrowstreet Capital, Limited Partnership0.49%August 5, 2026
July 2, 2026Arrowstreet Capital, Limited Partnership0.59%August 5, 2026
January 21, 2025Qube Research & Technologies Limited0.02%January 23, 2025
January 14, 2025Arrowstreet Capital, Limited Partnership0.60%August 5, 2026
January 3, 2025Qube Research & Technologies Limited0.70%January 23, 2025
December 20, 2024Arrowstreet Capital, Limited Partnership0.50%August 5, 2026
December 13, 2024Qube Research & Technologies Limited0.60%January 23, 2025
December 11, 2024Marshall Wace LLP0.48%December 13, 2024
December 2, 2024Qube Research & Technologies Limited0.59%January 23, 2025
November 26, 2024Qube Research & Technologies Limited0.61%January 23, 2025
November 25, 2024Qube Research & Technologies Limited0.59%January 23, 2025
November 14, 2024Qube Research & Technologies Limited0.68%January 23, 2025
November 13, 2024Qube Research & Technologies Limited0.70%January 23, 2025
November 5, 2024Qube Research & Technologies Limited0.61%January 23, 2025
October 30, 2024Qube Research & Technologies Limited0.54%January 23, 2025
October 17, 2024Marshall Wace LLP0.52%December 13, 2024
July 25, 2024Qube Research & Technologies Limited0.46%July 29, 2024
July 18, 2024Qube Research & Technologies Limited0.58%July 29, 2024
June 21, 2024Qube Research & Technologies Limited0.69%July 29, 2024
June 14, 2024Qube Research & Technologies Limited0.79%July 29, 2024
June 13, 2024Qube Research & Technologies Limited0.87%July 29, 2024
June 12, 2024Qube Research & Technologies Limited0.90%July 29, 2024
June 3, 2024Qube Research & Technologies Limited0.83%July 29, 2024
May 22, 2024Qube Research & Technologies Limited0.78%July 29, 2024
May 15, 2024Qube Research & Technologies Limited0.89%July 29, 2024
May 14, 2024Qube Research & Technologies Limited0.90%July 29, 2024
May 9, 2024Qube Research & Technologies Limited0.80%July 29, 2024
April 29, 2024Qube Research & Technologies Limited0.74%July 29, 2024
April 26, 2024Marshall Wace LLP0.46%April 30, 2024
April 18, 2024Qube Research & Technologies Limited0.61%July 29, 2024
April 12, 2024Marshall Wace LLP0.59%April 30, 2024
April 10, 2024Qube Research & Technologies Limited0.58%July 29, 2024
April 8, 2024Qube Research & Technologies Limited0.60%July 29, 2024
March 22, 2024Qube Research & Technologies Limited0.51%July 29, 2024
March 20, 2024Marshall Wace LLP0.60%April 30, 2024
March 12, 2024Marshall Wace LLP0.52%April 30, 2024
May 3, 2023Citadel Advisors LLC0.46%May 5, 2023
April 27, 2023Citadel Advisors LLC0.51%May 5, 2023
April 24, 2023Citadel Advisors LLC0.49%April 26, 2023
April 12, 2023Citadel Advisors LLC0.58%April 26, 2023
March 30, 2023Citadel Advisors LLC0.60%April 26, 2023
March 16, 2023Citadel Advisors LLC0.51%April 26, 2023
November 4, 2022Citadel Advisors LLC0.49%November 8, 2022
October 6, 2022Citadel Advisors LLC0.53%November 8, 2022
October 7, 2020Citadel Advisors LLC0.48%October 9, 2020
October 2, 2020Citadel Advisors LLC0.51%October 9, 2020
September 30, 2020Citadel Advisors LLC0.48%October 2, 2020
September 29, 2020Citadel Advisors LLC0.51%October 2, 2020
September 16, 2020Marshall Wace LLP0.49%September 18, 2020
August 11, 2020Marshall Wace LLP0.59%September 18, 2020

Other companies sold short in France

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Eramet, source AMF, data as at August 3, 2026, https://www.quivad.com/action/eramet